Literature DB >> 2967970

Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein.

A P Rice1, M B Mathews.   

Abstract

The human immunodeficiency virus 1 (HIV-1) long terminal repeat (LTR) sequences were inserted into adenovirus in place of the E1 region. The HIV-1 LTR contained in this recombinant adenovirus responds to trans-activation by tatIII in a HeLa cell line constitutively expressing that HIV-1 gene product. In addition, the HIV-1 LTR is activated by the adenovirus E1A 13S, but not 12S or 9S, gene product when it is supplied in trans by a coinfecting wild-type adenovirus. The Rous sarcoma virus LTR, in a similar recombinant adenovirus, is insensitive to tatIII but is also trans-activated by the E1A 13S protein. The action of the 13S E1A and tatIII proteins are additive for the HIV-1 LTR in the context of adenovirus and they appear to act at the transcriptional level. As in HeLa cells, the adenovirus-borne HIV-1 LTR is inactive in the absence of a trans-activator in H9 and Jurkat cells, two human leukemic T-cell lines. This suggests that recombinant adenoviruses have diagnostic potential for the detection of trans-activators of the HIV-1 LTR that are present in circulating human lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967970      PMCID: PMC280394          DOI: 10.1073/pnas.85.12.4200

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

2.  Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.

Authors:  C A Rosen; J G Sodroski; W C Goh; A I Dayton; J Lippke; W A Haseltine
Journal:  Nature       Date:  1986 Feb 13-19       Impact factor: 49.962

3.  Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells.

Authors:  B Zerler; B Moran; K Maruyama; J Moomaw; T Grodzicker; H E Ruley
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

4.  Lytic and transforming functions of individual products of the adenovirus E1A gene.

Authors:  E Moran; T Grodzicker; R J Roberts; M B Mathews; B Zerler
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

Authors:  M B Feinberg; R F Jarrett; A Aldovini; R C Gallo; F Wong-Staal
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

6.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

Authors:  J Sodroski; C Rosen; F Wong-Staal; S Z Salahuddin; M Popovic; S Arya; R C Gallo; W A Haseltine
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

7.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

Authors:  K A Jones; J T Kadonaga; P A Luciw; R Tjian
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

8.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

Authors:  B R Cullen
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

9.  Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription.

Authors:  E Borrelli; R Hen; P Chambon
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

10.  E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA.

Authors:  B Ferguson; B Krippl; O Andrisani; N Jones; H Westphal; M Rosenberg
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

View more
  26 in total

1.  Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols.

Authors:  T Yoshida; K Okuda; K Q Xin; K Tadokoro; J Fukushima; S Toda; E Hagiwara; K Hamajima; T Koshino; T Saito
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.

Authors:  K A Stellrecht; K Sperber; B G Pogo
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.

Authors:  M Kessler; M B Mathews
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

4.  Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.

Authors:  S F Parker; L K Felzien; N D Perkins; M J Imperiale; G J Nabel
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  E1a transactivation of human HSP70 gene promoter substitution mutants is independent of the composition of upstream and TATA elements.

Authors:  I C Taylor; R E Kingston
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

6.  Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.

Authors:  R Gentz; C H Chen; C A Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

7.  Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.

Authors:  R T Horvat; C Wood; N Balachandran
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Role for highly regulated rep gene expression in adeno-associated virus vector production.

Authors:  J Li; R J Samulski; X Xiao
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  E1a transactivation of the human HSP70 promoter is mediated through the basal transcriptional complex.

Authors:  G T Williams; T K McClanahan; R I Morimoto
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

10.  A directed evolution approach to select for novel Adeno-associated virus capsids on an HIV-1 producer T cell line.

Authors:  Dawn P Wooley; Priyanka Sharma; John R Weinstein; Poornima Kotha Lakshmi Narayan; David V Schaffer; Katherine J D A Excoffon
Journal:  J Virol Methods       Date:  2017-09-14       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.